Search |
Our History 2006: Approved for use nationally by the China FDA. 2008: CE Mark and ISO 13485. 2009: Several pilot studies and randomized clinical trials (RCTs) of ShangRing in Africa. 2012: United States FDA (501K) gave clearance for ShangRing. 2012: World Health Organization (WHO) initiated reviews from five RCTs and clinical studies of ShangRing use in three African countries (Kenya, Zambia and Uganda). 2013: Independent experts from a WHO Technical Advisory Group (TAG) reported over 99% of the circumcisions using ShangRing in the African studies were ... [Details] |